Pulmonx Total Liabilities and Share Holders Equity 2019-2024 | LUNG

Pulmonx total liabilities and share holders equity from 2019 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Pulmonx Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $178
2022 $194
2021 $235
2020 $264
2019 $54
2018 $15
Pulmonx Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $167
2024-06-30 $173
2024-03-31 $165
2023-12-31 $178
2023-09-30 $185
2023-06-30 $193
2023-03-31 $201
2022-12-31 $194
2022-09-30 $202
2022-06-30 $213
2022-03-31 $223
2021-12-31 $235
2021-09-30 $247
2021-06-30 $249
2021-03-31 $255
2020-12-31 $264
2020-09-30 $71
2020-06-30 $0
2020-03-31 $0
2019-12-31
2019-09-30 $0
2018-12-31 $15
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.230B $0.069B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.714B 55.57
Tempus AI (TEM) United States $7.994B 0.00
Hims & Hers Health (HIMS) United States $6.961B 177.00
Inspire Medical Systems (INSP) United States $5.693B 177.56
IRhythm Technologies (IRTC) United States $3.453B 0.00
Privia Health (PRVA) United States $2.701B 225.10
Enovis (ENOV) United States $2.693B 17.94
Azenta (AZTA) United States $2.440B 130.24
Clover Health Investments (CLOV) United States $2.230B 0.00
Omnicell (OMCL) United States $2.070B 67.71
Schrodinger (SDGR) United States $1.819B 0.00
10x Genomics (TXG) United States $1.796B 0.00
Phreesia (PHR) United States $1.669B 0.00
Butterfly Network (BFLY) United States $0.748B 0.00
Standard BioTools (LAB) United States $0.588B 0.00
Talkspace (TALK) United States $0.537B 0.00
Fulgent Genetics (FLGT) United States $0.515B 0.00
TruBridge (TBRG) United States $0.362B 105.43
Nyxoah SA (NYXH) Belgium $0.354B 0.00
Health Catalyst (HCAT) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.235B 0.00
American Well (AMWL) United States $0.169B 0.00
EUDA Health Holdings (EUDA) Singapore $0.096B 0.00
P3 Health Partners (PIII) United States $0.069B 0.00
CareCloud (CCLD) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
111 (YI) China $0.047B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.020B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00